MX2017007928A - Sistemas de modificación de genoma fúngico y métodos de uso. - Google Patents

Sistemas de modificación de genoma fúngico y métodos de uso.

Info

Publication number
MX2017007928A
MX2017007928A MX2017007928A MX2017007928A MX2017007928A MX 2017007928 A MX2017007928 A MX 2017007928A MX 2017007928 A MX2017007928 A MX 2017007928A MX 2017007928 A MX2017007928 A MX 2017007928A MX 2017007928 A MX2017007928 A MX 2017007928A
Authority
MX
Mexico
Prior art keywords
methods
genome modification
modification systems
fungal genome
compositions
Prior art date
Application number
MX2017007928A
Other languages
English (en)
Inventor
Ward Michael
Ge Jing
S Bower Benjamin
Chan Jimmy
Gu Xiaogang
Mampusti Madrid Susan
Song Danfeng
Song Mingmin
Original Assignee
Danisco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco Us Inc filed Critical Danisco Us Inc
Publication of MX2017007928A publication Critical patent/MX2017007928A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proporcionan composiciones y métodos para la modificación del genoma en un sitio diana en el genoma de una célula de hongo filamentoso. Los métodos y composiciones llevan a un polinucleótido guía/sistema de endonucleasa Cas para modificar o alterar el sitio diana. También se proporcionan aspectos en los que la célula de hongo filamentoso que se modifica tiene una ruta de extremos no homólogos defectuosa.
MX2017007928A 2014-12-16 2015-12-15 Sistemas de modificación de genoma fúngico y métodos de uso. MX2017007928A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN2014093916 2014-12-16
CN2014093914 2014-12-16
CN2014093918 2014-12-16
PCT/US2015/065693 WO2016100272A1 (en) 2014-12-16 2015-12-15 Fungal genome modification systems and methods of use

Publications (1)

Publication Number Publication Date
MX2017007928A true MX2017007928A (es) 2018-01-30

Family

ID=55083496

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2017007928A MX2017007928A (es) 2014-12-16 2015-12-15 Sistemas de modificación de genoma fúngico y métodos de uso.
MX2017008036A MX2017008036A (es) 2014-12-16 2015-12-16 Sistemas de modificacion del genoma fungico y metodos de uso.
MX2017007930A MX2017007930A (es) 2014-12-16 2015-12-16 Sistemas de modificación de genoma fúngico y métodos de uso.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2017008036A MX2017008036A (es) 2014-12-16 2015-12-16 Sistemas de modificacion del genoma fungico y metodos de uso.
MX2017007930A MX2017007930A (es) 2014-12-16 2015-12-16 Sistemas de modificación de genoma fúngico y métodos de uso.

Country Status (12)

Country Link
US (3) US11427829B2 (es)
EP (3) EP3234150B1 (es)
JP (3) JP6814142B2 (es)
KR (3) KR102350405B1 (es)
CN (3) CN107667171A (es)
AU (3) AU2015362784B2 (es)
BR (3) BR112017012837A2 (es)
CA (3) CA2971187C (es)
DK (3) DK3234150T3 (es)
FI (2) FI3234150T3 (es)
MX (3) MX2017007928A (es)
WO (3) WO2016100272A1 (es)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6261500B2 (ja) 2011-07-22 2018-01-17 プレジデント アンド フェローズ オブ ハーバード カレッジ ヌクレアーゼ切断特異性の評価および改善
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
WO2016022363A2 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
JP6892642B2 (ja) * 2015-04-13 2021-06-23 国立大学法人 東京大学 光依存的に又は薬物存在下でヌクレアーゼ活性若しくはニッカーゼ活性を示す、又は標的遺伝子の発現を抑制若しくは活性化するポリペプチドのセット
JP6937740B2 (ja) * 2015-07-28 2021-09-22 ダニスコ・ユーエス・インク ゲノム編集システムおよび使用方法
JP7109784B2 (ja) 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したＣａｓ９蛋白質
WO2017135317A1 (ja) * 2016-02-04 2017-08-10 花王株式会社 変異糸状菌の製造方法
DK3419992T3 (da) 2016-02-22 2021-02-15 Danisco Us Inc Svampesystem til proteinproduktion med højt udbytte
WO2017191210A1 (en) * 2016-05-04 2017-11-09 Novozymes A/S Genome editing by crispr-cas9 in filamentous fungal host cells
WO2018015444A1 (en) * 2016-07-22 2018-01-25 Novozymes A/S Crispr-cas9 genome editing with multiple guide rnas in filamentous fungi
KR102547316B1 (ko) 2016-08-03 2023-06-23 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018035388A1 (en) 2016-08-17 2018-02-22 The Broad Institute, Inc. Novel crispr enzymes and systems
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
WO2018064208A1 (en) 2016-09-28 2018-04-05 The Broad Institute, Inc. Systematic screening and mapping of regulatory elements in non-coding genomic regions, methods, compositions, and applications thereof
EP3523415A1 (en) 2016-10-04 2019-08-14 Danisco US Inc. Protein production in filamentous fungal cells in the absence of inducing substrates
EP3526320A1 (en) 2016-10-14 2019-08-21 President and Fellows of Harvard College Aav delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
JP6839424B2 (ja) * 2016-12-27 2021-03-10 国立大学法人 鹿児島大学 真菌におけるタンパク質の選択的分泌技術
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
JP2020510038A (ja) 2017-03-09 2020-04-02 プレジデント アンド フェローズ オブ ハーバード カレッジ がんワクチン
JP2020510439A (ja) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
CN110431224A (zh) 2017-03-13 2019-11-08 帝斯曼知识产权资产管理有限公司 锌双核簇转录调控因子缺陷型菌株
CA3057192A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018197020A1 (en) * 2017-04-27 2018-11-01 Novozymes A/S Genome editing by crispr-cas9 using short donor oligonucleotides
US11591601B2 (en) 2017-05-05 2023-02-28 The Broad Institute, Inc. Methods for identification and modification of lncRNA associated with target genotypes and phenotypes
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
KR20200026878A (ko) 2017-06-06 2020-03-11 지머젠 인코포레이티드 균류 균주를 개량하기 위한 htp 게놈 공학 플랫폼
WO2018227114A1 (en) 2017-06-09 2018-12-13 Editas Medicine, Inc. Engineered cas9 nucleases
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
WO2019046703A1 (en) * 2017-09-01 2019-03-07 Novozymes A/S METHODS OF ENHANCING GENOME EDITION IN FUNGI
KR20250107288A (ko) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 아데노신 염기 편집제의 용도
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
CN108085317B (zh) * 2018-01-17 2019-06-21 四川大学 一种特异性靶向变异链球菌gtfB位点的CRISPR-B基因编辑方法及应用
KR102822486B1 (ko) 2018-04-24 2025-06-18 다니스코 유에스 인크. 점도 감소 표현형을 포함하는 사상성 진균 균주
EP3797160A1 (en) 2018-05-23 2021-03-31 The Broad Institute Inc. Base editors and uses thereof
BR112020024839A2 (pt) 2018-06-06 2021-05-18 Zymergen Inc. manipulação de genes envolvidos em transdução de sinal para controlar a morfologia fúngica durante a fermentação e produção
EP3578658A1 (en) * 2018-06-08 2019-12-11 Johann Wolfgang Goethe-Universität Frankfurt Method for generating a gene editing vector with fixed guide rna pairs
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020028126A1 (en) 2018-07-30 2020-02-06 Danisco Us Inc Mutant and genetically modified filamentous fungal strains comprising enhanced protein productivity phenotypes and methods thereof
JP7460643B2 (ja) 2018-10-16 2024-04-02 ブルーアレル， エルエルシー 遺伝子へのｄｎａの標的化挿入のための方法
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
CN113039278A (zh) * 2018-10-31 2021-06-25 诺维信公司 通过指导的内切核酸酶和单链寡核苷酸进行基因组编辑
US12365888B2 (en) 2018-12-14 2025-07-22 Pioneer Hi-Bred International, Inc. CRISPR-Cas systems for genome editing
US12264323B2 (en) 2018-12-17 2025-04-01 The Broad Institute, Inc. CRISPR CPF1 direct repeat variants
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
US12215382B2 (en) 2019-03-01 2025-02-04 The General Hospital Corporation Liver protective MARC variants and uses thereof
US12534714B2 (en) 2019-03-18 2026-01-27 The Broad Institute, Inc. Type VII CRISPR proteins and systems
JP7657726B2 (ja) 2019-03-19 2025-04-07 ザ ブロード インスティテュート，インコーポレーテッド 編集ヌクレオチド配列を編集するための方法および組成物
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US20220235340A1 (en) 2019-05-20 2022-07-28 The Broad Institute, Inc. Novel crispr-cas systems and uses thereof
WO2021041922A1 (en) 2019-08-30 2021-03-04 The Broad Institute, Inc. Crispr-associated mu transposase systems
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
CA3155372A1 (en) 2019-10-28 2021-05-06 Sharief Barends Microbial host cells for the production of heterologous cyanuric acid hydrolases and biuret hydrolases
FI4055177T3 (fi) 2019-11-08 2024-10-31 Danisco Us Inc Parantuneen proteiinituottavuuden fenotyyppejä käsittäviä sienikantoja ja menetelmiä niitä varten
EP4139332A1 (en) 2020-04-22 2023-03-01 Danisco US Inc. Compositions and methods for enhanced protein production in filamentous fungal cells
DE112021002672T5 (de) 2020-05-08 2023-04-13 President And Fellows Of Harvard College Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
US20230340539A1 (en) * 2020-05-26 2023-10-26 Zymergen Inc. Methods of transient protein and gene expression in cells
US11479779B2 (en) 2020-07-31 2022-10-25 Zymergen Inc. Systems and methods for high-throughput automated strain generation for non-sporulating fungi
CN117716039A (zh) 2021-07-19 2024-03-15 丹尼斯科美国公司 用于增强真菌细胞中的蛋白质产生的组合物和方法
US20240352499A1 (en) 2021-08-20 2024-10-24 Danisco Us Inc. Polynucleotides encoding novel nucleases, compositions thereof and methods thereof for eliminating dna from protein preparations
EP4399295A1 (en) 2021-09-09 2024-07-17 International N&H Denmark ApS Over expression of foldases and chaperones improves protein production
JP2024542623A (ja) 2021-12-01 2024-11-15 ダニスコ・ユーエス・インク 真菌細胞におけるタンパク質生産を増強するための組成物及び方法
CN114410635B (zh) * 2022-03-29 2022-06-14 中国科学院天津工业生物技术研究所 威尼斯镰刀菌内源U6启动子及其基于CRISPR/Cas9的基因编辑方法
AU2023306398A1 (en) 2022-07-15 2025-01-23 International N&H Denmark Aps Improved enzymatic modification of phospholipids in food
WO2024102556A1 (en) 2022-11-11 2024-05-16 Danisco Us Inc. Filamentous fungal strains comprising enhanced protein productivity phenotypes and methods thereof
JPWO2024122646A1 (es) * 2022-12-08 2024-06-13
CN120390792A (zh) 2022-12-19 2025-07-29 丹尼斯科美国公司 重组真菌菌株及其用于产生一致性蛋白质的方法
JP2026505371A (ja) 2023-02-08 2026-02-13 ダニスコ・ユーエス・インク 糸状真菌細胞において異種グロビンを産生するための組成物及び方法
EP4689096A1 (en) 2023-03-27 2026-02-11 Danisco US Inc. Reduced fermentation glycerol and acetate using yeast expressing rubisco from gallionella capsiferriformans
KR20250000949A (ko) * 2023-06-26 2025-01-06 전북대학교산학협력단 시그마-54 및 MmoR을 통한 선택적 메탄 모노옥시게나제의 고효율 생산 방법
CN121752712A (zh) 2023-06-30 2026-03-27 丹尼斯科美国公司 用于凝集素工业规模生产的重组真菌细胞及其方法
CN116769781B (zh) * 2023-08-16 2023-10-24 中国科学院天津工业生物技术研究所 一种来源于粗壮脉纹孢菌的启动子及其应用
WO2025059533A1 (en) 2023-09-13 2025-03-20 The Broad Institute, Inc. Crispr enzymes and systems
WO2025207802A1 (en) 2024-03-27 2025-10-02 Nutrition & Biosciences USA 4, Inc. Recombinant microbial strains comprising reduced beta-oxidation phenotypes and methods thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5107065A (en) 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5290474A (en) 1990-10-05 1994-03-01 Genencor International, Inc. Detergent composition for treating cotton-containing fabrics containing a surfactant and a cellulase composition containing endolucanase III from trichoderma ssp
US6436643B1 (en) * 1997-12-22 2002-08-20 Unilever Patent Holdings Bv Process for site-directed integration of multiple copies of a gene in a mould
ATE524491T1 (de) 2003-05-29 2011-09-15 Genencor Int Neue trichoderma-gene
CN102174490B (zh) 2003-11-21 2016-09-28 丹尼斯科美国公司 颗粒淀粉水解酶在木霉菌中的表达和从颗粒淀粉底物产生葡萄糖的方法
AU2005249422B2 (en) 2004-05-27 2011-03-17 Genencor International, Inc. Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions
BR112012030746A2 (pt) 2010-06-03 2016-02-16 Danisco Us Inc cepas hospedeiras fúngigas filamentosas e constructos de dna , e métodos de uso dos mesmos.
WO2013141680A1 (en) 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
EP4357457B1 (en) * 2012-10-23 2024-10-16 Toolgen Incorporated Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
AU2013359262C1 (en) * 2012-12-12 2021-05-13 Massachusetts Institute Of Technology CRISPR-Cas component systems, methods and compositions for sequence manipulation
US8697359B1 (en) * 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
US20160122774A1 (en) * 2013-05-29 2016-05-05 Cellectis A method for producing precise dna cleavage using cas9 nickase activity
US11685935B2 (en) 2013-05-29 2023-06-27 Cellectis Compact scaffold of Cas9 in the type II CRISPR system
WO2015054507A1 (en) 2013-10-10 2015-04-16 Pronutria, Inc. Nutritive polypeptide production systems, and methods of manufacture and use thereof
MX2016007325A (es) * 2013-12-12 2017-07-19 Broad Inst Inc Composiciones y metodos de uso de sistemas crispr-cas en desordenes debidos a repeticion de nucleotidos.
WO2015138855A1 (en) * 2014-03-14 2015-09-17 The Regents Of The University Of California Vectors and methods for fungal genome engineering by crispr-cas9
SG11201700446XA (en) * 2014-07-21 2017-02-27 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
US10513711B2 (en) * 2014-08-13 2019-12-24 Dupont Us Holding, Llc Genetic targeting in non-conventional yeast using an RNA-guided endonuclease
DK3242950T3 (da) * 2015-01-06 2021-12-20 Dsm Ip Assets Bv Crispr-cas-system til en trådformet svampeværtscelle

Also Published As

Publication number Publication date
CN107278231A (zh) 2017-10-20
DK3234150T3 (da) 2025-11-03
KR20170087522A (ko) 2017-07-28
JP6814143B2 (ja) 2021-01-13
AU2015364632A1 (en) 2017-07-06
US11401522B2 (en) 2022-08-02
WO2016100571A1 (en) 2016-06-23
WO2016100272A1 (en) 2016-06-23
KR102350405B1 (ko) 2022-01-11
CN107257859A (zh) 2017-10-17
EP3234152B1 (en) 2021-09-15
BR112017012850A2 (pt) 2017-12-26
JP2018504895A (ja) 2018-02-22
EP3234150B1 (en) 2025-08-13
EP3234151B1 (en) 2025-08-13
AU2015362784B2 (en) 2021-05-13
KR20170089931A (ko) 2017-08-04
US20180002710A1 (en) 2018-01-04
KR102350404B1 (ko) 2022-01-11
JP2017537647A (ja) 2017-12-21
CA2971248C (en) 2023-04-04
CA2971187A1 (en) 2016-06-23
AU2015364629A1 (en) 2017-07-06
CA2971187C (en) 2023-10-24
JP2017538425A (ja) 2017-12-28
BR112017012837A2 (pt) 2017-12-26
US11098314B2 (en) 2021-08-24
US20190093114A1 (en) 2019-03-28
CA2971247A1 (en) 2016-06-23
EP3234151A1 (en) 2017-10-25
JP6814141B2 (ja) 2021-01-13
FI3234150T3 (fi) 2025-11-05
JP6814142B2 (ja) 2021-01-13
BR112017012851A2 (pt) 2017-12-26
US20170369891A1 (en) 2017-12-28
MX2017007930A (es) 2018-01-11
DK3234151T3 (da) 2025-11-03
KR102350402B1 (ko) 2022-01-11
EP3234152A1 (en) 2017-10-25
AU2015364632B2 (en) 2021-05-13
DK3234152T3 (da) 2021-12-20
CA2971248A1 (en) 2016-06-23
CN107667171A (zh) 2018-02-06
WO2016100568A1 (en) 2016-06-23
MX2017008036A (es) 2017-09-28
AU2015362784A1 (en) 2017-07-06
EP3234150A1 (en) 2017-10-25
AU2015364629B2 (en) 2021-05-13
US11427829B2 (en) 2022-08-30
KR20170087521A (ko) 2017-07-28
FI3234151T3 (fi) 2025-11-05

Similar Documents

Publication Publication Date Title
MX2017007928A (es) Sistemas de modificación de genoma fúngico y métodos de uso.
IL320861B1 (en) Preparations and methods for internalizing enzymes
ZA202100808B (en) Methods and compositions for improving plant traits
MX2025006476A (es) Composiciones y metodos para oncologia inmunologica
EP3110945A4 (en) Compositions and methods for site directed genomic modification
SI3108009T1 (sl) Postopki in sestavki za profiliranje DNK
IL251576A0 (en) Methods and compositions for creating or maintaining multifunctional cells
EP3097212A4 (en) Methods and compositions for sequences guiding cas9 targeting
EP3126628A4 (en) Focused symmetric pipe inspection tools
EP3209815A4 (en) Corrosion inhibitors and related compositions and methods
EP3212225A4 (en) Methods and compositions for modified t cells
EP3201340A4 (en) Methods for increasing efficiency of nuclease-induced homology-directed repair
SG11201608503UA (en) Methods and compositions for modifying genomic dna
SG11201704646YA (en) Methods and compositions for targeted genetic modification through single-step multiple targeting
EP3380622A4 (en) METHODS AND COMPOSITIONS FOR MODIFYING IMMUNITY
EP3215139A4 (en) Compositions and methods for improved car-t cell therapies
EP3097414A4 (en) Systems and methods for delivering liquid to an ion source
EP3145516A4 (en) Methods and compositions for treating malignancies with dendritic cells
IL259590A (en) Preparations and methods for manipulating plant growth
EP3191301A4 (en) Compositions and methods for fiber-containing grout
EP3201138A4 (en) Compositions and methods for selective anion removal
WO2016014319A9 (en) Animal containment enrichment compositions and methods
ZA201606811B (en) Compositions and methods for identifying ehrlichia species
EP3313386A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS
EP3114238A4 (en) Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy